Fig. 3From: The trend of dental check-up and prevalence of dental complications following the use of bone modifying agents in patients with metastatic breast and prostate cancer: analysis of data from the Korean National Health Insurance ServicePrevalence of dental adverse events after BMA treatment since 2007Back to article page